JOURNAL ARTICLE

The Acute Interference of Biotin in Blood Analysis.

  • Published In: Mental Health Weekly Digest, 2026. P. 862 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

The article discusses a newly launched clinical trial (NCT07302880) aimed at investigating the acute effects of biotin supplementation on laboratory assays, particularly focusing on its interference with immunoassays that utilize the streptavidin-biotin interaction. Biotin, or vitamin B7, is essential for metabolic processes and is commonly used as a supplement for hair and nail growth. The trial will evaluate how different doses of biotin (10 mg and 100 mg) affect plasma levels of thyroid peroxidase antibodies (TPOAb) and other blood proteins over a period of time following ingestion. The study is set to begin in January 2026 and aims to provide insights that could inform guidelines for interpreting test results in patients who have recently taken biotin supplements. [Extracted from the article]

Additional Information

  • Source:Mental Health Weekly Digest. 2026/01, p862
  • Document Type:Article
  • Subject Area:Nutrition and Dietetics
  • Publication Date:2026
  • ISSN:1543-6616
  • Accession Number:190628570
  • Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.